Acquired hemophilia A
Other Names for this Disease
- Acquired factor 8 deficiency
- Acquired factor VII deficiency
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- ClinicalTrials.gov lists trials that are studying or have studied Acquired hemophilia A. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
|Generic Name||antihemophilic factor (recombinant), Fc fusion protein|
(Biogen Idec Inc.)
The FDA has approved this product to be used in this manner.
|Treatment of adults and children with Hemophilia A (congenital Factor VIII deficiency) for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.|
|More Information about this product||Drug Information Portal|